Celator(R) Pharmaceuticals Announces Publication of Positive Phase 2 Data With CPX-351 in Acute Myeloid Leukemia Patients
May 27, 2014 at 08:33 AM EDT
Celator Pharmaceuticals, Inc. (Nasdaq: CPXX), announced the publication of the Phase 2 study evaluating CPX-351 in newly diagnosed ...